The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of neoadjuvant chemotherapy with xeloda and oxaliplatin (G-XELOX) for locally advanced gastric cancer.
 
Hironaga Satake
No Relationships to Disclose
 
Masato Kondo
No Relationships to Disclose
 
Takeshi Kotake
No Relationships to Disclose
 
Yoshihiro Okita
No Relationships to Disclose
 
Takatsugu Ogata
No Relationships to Disclose
 
Yukimasa Hatachi
No Relationships to Disclose
 
Hisateru Yasui
No Relationships to Disclose
 
Satoshi Kaihara
No Relationships to Disclose
 
Masahito Kotaka
Speakers' Bureau - Chugai Pharma; Merck Serono; Takeda
 
Takeshi Kato
Speakers' Bureau - Bayer; Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma; Yakult Honsha
Expert Testimony - Lilly
Travel, Accommodations, Expenses - Eisai
 
Akihito Tsuji
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda
Speakers' Bureau - Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda